Terms: = Bone cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2
95 results:
1. Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patients.
Stepien N; Mayr L; Schmook MT; Raimann A; Dorfer C; Peyrl A; Azizi AA; Schramm K; Haberler C; Gojo J
Pediatr Blood Cancer; 2024 Mar; 71(3):e30836. PubMed ID: 38177074
[TBL] [Abstract] [Full Text] [Related]
2. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
3. Cell-based screen identifies porphyrins as fgfr3 activity inhibitors with therapeutic potential for achondroplasia and cancer.
Lin YW; Kao HJ; Chen WT; Kao CF; Wu JY; Chen YT; Lee YC
JCI Insight; 2023 Nov; 8(22):. PubMed ID: 37824212
[TBL] [Abstract] [Full Text] [Related]
4. Clinical-genetic analysis of selected genes involved in the development of the human skeleton in 128 Czech patients with suspected congenital skeletal abnormalities.
Spurná Z; Čapková P; Punová L; DuchoslavovÁ J; Aleksijevic D; Venháčová P; Srovnal J; Štellmachová J; Curtisová V; Bitnerová V; Petřková J; Kolaříková K; Janíková M; Kratochvílová R; Vrtěl P; Vodička R; Vrtěl R; Zapletalová J
Gene; 2024 Jan; 892():147881. PubMed ID: 37806643
[TBL] [Abstract] [Full Text] [Related]
5. Exosomal miR-99b-5p Secreted from Mesenchymal Stem Cells Can Retard the Progression of Colorectal cancer by Targeting fgfr3.
Ning S; Chen Y; Li S; Liu M; Liu H; Ye M; Wang C; Pan J; Wei W; Li J; Zhang L
Stem Cell Rev Rep; 2023 Nov; 19(8):2901-2917. PubMed ID: 37653181
[TBL] [Abstract] [Full Text] [Related]
6. Erdafitinib in the Treatment of Metastatic Urothelial Carcinoma.
Castro-Alonso FJ; Beas-Lozano E; Remolina-Bonilla YA; Flaig TW; Bourlon MT
Oncology (Williston Park); 2023 Jun; 37(6):256-261. PubMed ID: 37343207
[TBL] [Abstract] [Full Text] [Related]
7. Activated fgfr3 suppresses bone regeneration and bone mineralization in an ovariectomized mouse model.
Kawashima I; Matsushita M; Mishima K; Kamiya Y; Osawa Y; Ohkawara B; Ohno K; Kitoh H; Imagama S
BMC Musculoskelet Disord; 2023 Mar; 24(1):200. PubMed ID: 36927417
[TBL] [Abstract] [Full Text] [Related]
8. Identification of long noncoding RNA
Chen T; Sun Z; Cui Y; Ji J; Li Y; Qu X
Hematology; 2023 Dec; 28(1):2164449. PubMed ID: 36657019
[TBL] [Abstract] [Full Text] [Related]
9. Multiple Therapeutic Applications of RBM-007, an Anti-FGF2 Aptamer.
Nakamura Y
Cells; 2021 Jun; 10(7):. PubMed ID: 34203430
[TBL] [Abstract] [Full Text] [Related]
10. ETV4 and ETV5 drive synovial sarcoma through cell cycle and DUX4 embryonic pathway control.
DeSalvo J; Ban Y; Li L; Sun X; Jiang Z; Kerr DA; Khanlari M; Boulina M; Capecchi MR; Partanen JM; Chen L; Kondo T; Ornitz DM; Trent JC; Eid JE
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 33983905
[TBL] [Abstract] [Full Text] [Related]
11. Detection of activating mutations in liquid biopsy of Egyptian breast cancer patients using targeted next-generation sequencing: a pilot study.
Kassem N; Kassem H; Kassem L; Hassan M
J Egypt Natl Canc Inst; 2021 Apr; 33(1):10. PubMed ID: 33864517
[TBL] [Abstract] [Full Text] [Related]
12. Oral cancer in the Indian Subcontinent-Survival Outcomes and Risk Factors with Primary Surgery.
Thakar A; Thakur R; Kakkar A; Malhotra RK; Singh CA; Sikka K; Kumar R; Pramanik R; Biswas A; Bhalla AS; Bhaskar S; Sharma A
Laryngoscope; 2021 Oct; 131(10):2254-2261. PubMed ID: 33797083
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of FGFR inhibitor ASP5878 as a drug candidate for achondroplasia.
Ozaki T; Kawamoto T; Iimori Y; Takeshita N; Yamagishi Y; Nakamura H; Kamohara M; Fujita K; Tanahashi M; Tsumaki N
Sci Rep; 2020 Dec; 10(1):20915. PubMed ID: 33262386
[TBL] [Abstract] [Full Text] [Related]
14. A brief guide to pustular psoriasis for primary care providers.
Crowley JJ; Pariser DM; Yamauchi PS
Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
[TBL] [Abstract] [Full Text] [Related]
15. Prostate cancer-derived MMP-3 controls intrinsic cell growth and extrinsic angiogenesis.
Frieling JS; Li T; Tauro M; Lynch CC
Neoplasia; 2020 Oct; 22(10):511-521. PubMed ID: 32896761
[TBL] [Abstract] [Full Text] [Related]
16. Evolution and structure of clinically relevant gene fusions in multiple myeloma.
Foltz SM; Gao Q; Yoon CJ; Sun H; Yao L; Li Y; Jayasinghe RG; Cao S; King J; Kohnen DR; Fiala MA; Ding L; Vij R
Nat Commun; 2020 May; 11(1):2666. PubMed ID: 32471990
[TBL] [Abstract] [Full Text] [Related]
17. High-risk cytogenetics in multiple myeloma: Further scrutiny of deletions within the IGH gene region enhances risk stratification.
Smith SC; Althof PA; Dave BJ; Sanmann JN
Genes Chromosomes Cancer; 2020 Oct; 59(10):569-574. PubMed ID: 32447782
[TBL] [Abstract] [Full Text] [Related]
18. Thoracolumbar corpectomy/spondylectomy for spinal metastasis: a pooled analysis comparing the outcome of seven different surgical approaches.
Spiessberger A; Arvind V; Gruter B; Cho SK
Eur Spine J; 2020 Feb; 29(2):248-256. PubMed ID: 31641907
[TBL] [Abstract] [Full Text] [Related]
19. Preventing Restenosis of Marsupialized Rathke Cleft Cysts Using a Nasoseptal Flap Lining.
Kuan EC; Trent MS; Luu NN; Kohanski MA; Tong CC; O'Malley BW; Adappa ND; Palmer JN
Laryngoscope; 2019 Oct; 129(10):2258-2261. PubMed ID: 31038765
[TBL] [Abstract] [Full Text] [Related]
20. Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia.
Jerchel IS; Hoogkamer AQ; Ariës IM; Boer JM; Besselink NJM; Koudijs MJ; Pieters R; den Boer ML
Sci Rep; 2019 Feb; 9(1):1875. PubMed ID: 30755670
[TBL] [Abstract] [Full Text] [Related]
[Next]
